Epigenetic priming to resensitize chemotherapy. Derangements in multiple epigenetic processes lead to shifts in entire networks of signaling pathways, tumor suppressors, oncogenes, DNA-damage response, cell cycle, autophagy and protein degradation, and immune surveillance and apoptosis.